𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

✍ Scribed by Michael Yellin; Igor Paliienko; Andra Balanescu; Semen Ter-Vartanian; Vira Tseluyko; Li-An Xu; Xiaolu Tao; Pina M. Cardarelli; Heidi LeBlanc; Geoff Nichol; Codrina Ancuta; Rodica Chirieac; Allison Luo


Book ID
112002637
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
199 KB
Volume
64
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES